Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.82
Delayed Data
As of May 22
 +0.11 / +1.64%
Today’s Change
3.71
Today|||52-Week Range
11.49
+49.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash1.5M4.4M2.3M1.8M
 
 
 
 
 
Short Term Investment Cash313.7K2.9M-2.2M-510.0K
 
 
 
 
 
Cash & Short Term Investments3.7M5.1M8.5M21.3M
 
 
 
 
 
 
ReceivablesReceivables567.1K172.7K153.0K408.0K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses1.7K2.3K----
 
 
 
Other Current Assets0.000.000.0064.0K
 
 
Current Assets4.3M5.3M8.6M21.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross123.5K125.6K130.3K144.0K
 
 
 
 
 
Depreciation-106.1K-120.8K-124.5K-130.0K
 
 
 
 
 
Other Assets24.5K12.6K7.5K7.0K
 
 
 
 
 
Total Assets4.3M5.3M8.7M21.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable386.3K628.0K439.5K--
 
 
 
 
Accrued Expenses------973.0K
 
 
Other Current Liabilities18.5K0.000.00973.0K
 
 
 
Other Liabilities441.3K644.4K498.2K973.0K
 
 
 
 
 
 
Total LiabilitiesOther Liabilities0.00637.2K0.000.00
 
 
Total Liabilities602.0K1.5M529.4K1.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity3.7M3.8M8.1M20.8M
 
 
 
 
 
Total Shareholder Equity3.7M3.8M8.1M20.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding5.8M6.7M7.9M10.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account